Next Article in Journal
Consensus Recommendations for the Diagnosis and Management of Well-Differentiated Gastroenterohepatic Neuroendocrine Tumours: A Revised Statement from a Canadian National Expert Group
Previous Article in Journal
Epidermal Growth Factor Receptor Targeted Therapy in Stages III and IV Head and Neck Cancer
 
 
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Letter

Balancing Potential Quality-of-Life Benefits Against the Risk of Lethal Late Recurrence with Bladder-Preserving Surgery

Professor of Surgery, University of Toronto Chief of Urology, Sunnybrook Health Sciences Centre 2075 Bayview Avenue, Suite MG-408 Toronto, ON M4N 3M5, USA
Submission received: 1 May 2010 / Revised: 4 May 2010 / Accepted: 8 May 2010 / Published: 1 June 2010

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

The authors make a clear case for the role of bladder preservation strategies in selected patients [...]
Keywords: bladder cancer; bladder-sparing approach; radical cystectomy bladder cancer; bladder-sparing approach; radical cystectomy

Share and Cite

MDPI and ACS Style

Klotz, L. Balancing Potential Quality-of-Life Benefits Against the Risk of Lethal Late Recurrence with Bladder-Preserving Surgery. Curr. Oncol. 2010, 17, 4. https://0-doi-org.brum.beds.ac.uk/10.3747/co.v17i3.544

AMA Style

Klotz L. Balancing Potential Quality-of-Life Benefits Against the Risk of Lethal Late Recurrence with Bladder-Preserving Surgery. Current Oncology. 2010; 17(3):4. https://0-doi-org.brum.beds.ac.uk/10.3747/co.v17i3.544

Chicago/Turabian Style

Klotz, Laurence. 2010. "Balancing Potential Quality-of-Life Benefits Against the Risk of Lethal Late Recurrence with Bladder-Preserving Surgery" Current Oncology 17, no. 3: 4. https://0-doi-org.brum.beds.ac.uk/10.3747/co.v17i3.544

Article Metrics

Back to TopTop